David S. Hong
1994–2026 年に発表
- 別表記
- David S Hong
- 305
- 論文数
- 40,972
- 被引用数
- 110
- h 指数
- 293
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine54.8%
- Biochemistry, Genetics and Molecular Biology35.5%
- Immunology and Microbiology4%
- Engineering1%
- Neuroscience0.9%
- Computer Science0.8%
- その他3%
トピック
- Cancer Genomics and Diagnostics4.4%
- Cancer Immunotherapy and Biomarkers4.4%
- Lung Cancer Treatments and Mutations3.8%
- MicroRNA in disease regulation1.9%
- Colorectal Cancer Treatments and Studies1.9%
- Immunotherapy and Immune Responses1.8%
- その他81.8%
共著者
- Aung Naing78
- Sarina A. Piha‐Paul64
- Razelle Kurzrock61
- Siqing Fu61
- Funda Meric‐Bernstam59
- Filip Jankú55
- Apostolia M. Tsimberidou53
- Gerald S. Falchook49
- Vivek Subbiah41
- Daniel D. Karp33
- Jennifer J. Wheler30
- Alexander Drilon22
- John H. Strickler20
- Scott Kopetz20
- Kenneth R. Hess18
- Shubham Pant18
- John V. Heymach17
- Ignacio Garrido‐Laguna16
- Shivaani Kummar15
- Ecaterina E. Dumbrava14
- Jordi Rodón14
- Timothy A. Yap14
- James W. Welsh13
- Theodore W. Laetsch13
全論文
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
著者: Jude Canon, Karen Rex, Anne Y. Saiki, Christopher Mohr, Keegan S. Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G. Knutson, Neelima Koppada, Brian A. Lanman, Jonathan Werner, Aaron S. Rapaport, Tisha San Miguel, Roberto Ortiz, Tao Osgood, Ji-Rong Sun, Xiaochun Zhu, John D. McCarter, Laurie P. Volak, Brett E. Houk, Marwan Fakih, Bert H. O’Neil, Timothy Price, Gerald S. Falchook, Jayesh Desai, James Kuo, Ramaswamy Govindan, David S. Hong, Wenjun Ouyang, Haby Henary, Tara Arvedson, Victor J. Cee, J. Russell Lipford - Nature 2019 被引用: 2,303
- KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
著者: David S. Hong, Marwan Fakih, John H. Strickler, Jayesh Desai, Gregory A. Durm, Geoffrey I. Shapiro, Gerald S. Falchook, Timothy Price, Adrian G. Sacher, Crystal S. Denlinger, Yung‐Jue Bang, Grace K. Dy, John C. Krauss, Yasutoshi Kuboki, James Kuo, Andrew L. Coveler, Keunchil Park, Tae Won Kim, Fabrice Barlési, Pamela N. Münster, Suresh S. Ramalingam, Timothy F. Burns, Funda Meric‐Bernstam, Haby Henary, Jude Ngang, Gataree Ngarmchamnanrith, June Myung Kim, Brett E. Houk, Jude Canon, J. Russell Lipford, Gregory Friberg, Piro Lito, Ramaswamy Govindan, Bob T. Li - New England Journal of Medicine 2020 被引用: 1,687
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
著者: Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen, George D. Demetri, Michael J. Nathenson, Robert C. Doebele, Anna F. Farago, Alberto S. Pappo, Brian Turpin, Afshin Dowlati, Marcia S. Brose, Leo Mascarenhas, Noah Federman, Jordan Berlin, Wafik S. El‐Deiry, Christina S. Baik, John F. Deeken, Valentina Boni, Ramamoorthy Nagasubramanian, Matthew H. Taylor, Erin R. Rudzinski, Funda Meric‐Bernstam, Davendra Sohal, C. Patrick, Luis E. Raez, Jaclyn F. Hechtman, Ryma Benayed, Marc Ladanyi, Brian B. Tuch, Kevin Ebata, Scott Cruickshank, Nora Ku, Michael C. Cox, Douglas S. Hawkins, David S. Hong, David M. Hyman - New England Journal of Medicine 2018 被引用: 2,728
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
著者: David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad, Jasgit C. Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew Brenner, Keunchil Park, Jae‐Lyun Lee, Tae‐You Kim, SangJoon Shin, Carlos Becerra, Gerald S. Falchook, Jay Stoudemire, Desiree Martin, Kevin Kelnar, Heidi J. Peltier, Vinícius Bonato, Andreas G. Bader, Susan Smith, Sinil Kim, Vincent O’Neill, Muhammad Shaalan Beg - British Journal of Cancer 2020 被引用: 912
- Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
著者: David S. Hong, Steven G. DuBois, Shivaani Kummar, Anna F. Farago, Catherine M. Albert, Kristoffer Staal Rohrberg, Cornelis M. van Tilburg, Ramamoorthy Nagasubramanian, Jordan Berlin, Noah Federman, Leo Mascarenhas, Birgit Geoerger, Afshin Dowlati, Alberto S. Pappo, Stefan Bielack, François Doz, Ray McDermott, Jyoti D. Patel, Russell J. Schilder, Makoto Tahara, Stefan M. Pfister, Olaf Witt, Marc Ladanyi, Erin R. Rudzinski, Shivani Nanda, Barrett H. Childs, Theodore W. Laetsch, David M. Hyman, Alexander Drilon - The Lancet Oncology 2020 被引用: 994
- Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
著者: John H. Strickler, Hironaga Satake, Thomas J. George, Rona Yaeger, Antoine Hollebecque, Ignacio Garrido‐Laguna, Martin Schüler, Timothy F. Burns, Andrew L. Coveler, Gerald S. Falchook, Mark Vincent, Yu Sunakawa, Laëtitia Dahan, David L. Bajor, Sun Young Rha, Charlotte Lemech, Dejan Juric, Marko Rehn, Gataree Ngarmchamnanrith, Pegah Jafarinasabian, Qui Tran, David S. Hong - New England Journal of Medicine 2022 被引用: 468
- Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
著者: Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam, Hagop M. Kantarjian, Farhad Ravandi, Meghan Collins, Maria Emilia Di Francesco, Ecaterina E. Dumbrava, Siqing Fu, Sisi Gao, Jason Gay, Sonal Gera, Jing Han, David S. Hong, Elias Jabbour, Zhenlin Ju, Daniel D. Karp, Alessia Lodi, Jennifer R. Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A. Piha‐Paul, Jordi Rodón, Carolina Salguero, Koji Sasaki, Anand Kumar Singh, Vivek Subbiah, Apostolia M. Tsimberidou, Quanyun A. Xu, Musa Yılmaz, Qi Zhang, Yuan Li, Christopher A. Bristow, Meenakshi B. Bhattacharjee, Stefano Tiziani, Timothy P. Heffernan, Christopher P. Vellano, Philip Jones, Cobi J. Heijnen, Annemieke Kavelaars, Joseph R. Marszalek, Marina Konopleva - Nature Medicine 2023 被引用: 377
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
著者: Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev, Mitesh J. Borad, Yoon‐Koo Kang, Jay Stoudemire, Susan Smith, Andreas G. Bader, Sinil Kim, David S. Hong - Investigational New Drugs 2016 被引用: 884
- Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
著者: Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou, Lukas Delasos, J. Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V. Aredo, Michael J. Dennis, Turja Chakrabarti, Susan C. Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W. Riess, So Yeon Kim, Sarah B. Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong, Richard Lee, Biagio Ricciuti, Joao V. Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 被引用: 181
- Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
著者: Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster, John C Krauss, Gerald S Falchook, Sae-Won Han, Volker Heinemann, Kei Muro, John H Strickler, David S Hong, Crystal S Denlinger, Gustavo Girotto, Myung-Ah Lee, Haby Henary, Qui Tran, Joseph K Park, Gataree Ngarmchamnanrith, Hans Prenen, Timothy J Price - The Lancet Oncology 2021 被引用: 288
- Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
著者: Julien Dilly, Megan T. Hoffman, Laleh Abbassi, Ziyue Li, Francesca Paradiso, Brendan D. Parent, Connor J. Hennessey, Alexander C. Jordan, Micaela Morgado, Shatavisha Dasgupta, Giselle A. Uribe, Annan Yang, Kevin S. Kapner, Felix P. Hambitzer, Qiang Li, Hanrong Feng, Jacob Geisberg, Junning Wang, Kyle E. Evans, Hengyu Lyu, Aislyn Schalck, Ningping Feng, Anastasia M. Lopez, Christopher A. Bristow, Michael P. Kim, Kimal Rajapakshe, Vahid Bahrambeigi, Jennifer A. Roth, Kavita S. Garg, Paola A. Guerrero, Ben Z. Stanger, Simona Cristea, Scott W. Lowe, Timour Baslan, Eliezer M. Van Allen, Joseph D. Mancias, Emily Chan, Abraham Anderson, Yuliya V. Katlinskaya, Alex K. Shalek, David S. Hong, Shubham Pant, Jill Hallin, Kenna Anderes, Peter Olson, Timothy P. Heffernan, Seema Chugh, James G. Christensen, Anirban Maitra, Brian M. Wolpin, Srivatsan Raghavan, Jonathan A. Nowak, Peter Winter, Stephanie K. Dougan, Andrew J. Aguirre - Cancer Discovery 2024 被引用: 234
- Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial
著者: David S. Hong, Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski, Jeffrey Clarke, Dejka M. Araujo, George R. Blumenschein, Partow Kebriaei, Quan Lin, Alex J. Tipping, Joseph P. Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane P. F. Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean‐Marc Navenot, Frederic D. Bushman, J.K. Everett, Derin F. Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G. Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda F. Cashen, Anne Grand’Maison, Philip L. McCarthy, Paula M. Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A. Liebner, Kunle Odunsi, Marcus O. Butler - Nature Medicine 2023 被引用: 194
- Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
著者: Grace K. Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S. Falchook, Antoîne Italiano, Jürgen Wolf, Adrian G. Sacher, Toshiaki Takahashi, Suresh S. Ramalingam, Christophe Dooms, Dong‐Wan Kim, Alfredo Addeo, Jayesh Desai, Martin Schüler, Pascale Tomasini, David S. Hong, Piro Lito, Qui Tran, Simon Jones, Abraham Anderson, Antreas Hindoyan, Wendy Snyder, Ferdinandos Skoulidis, Bob T. Li - Journal of Clinical Oncology 2023 被引用: 149
- 652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)
著者: Kathryn C. Arbour, Salman R. Punekar, Ignacio Garrido‐Laguna, David S. Hong, Brian M. Wolpin, Meredith S. Pelster, M. Barve, Alexander Starodub, D. Sommerhalder, Sam S. Chang, Y. Zhang, Zeena Salman, X. Wang, Corinne E. Gustafson, Alexander I. Spira - Annals of Oncology 2023 被引用: 115
- Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
著者: Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín, María Ochoa-de-Olza, John Sarantopoulos, Richard D. Carvajal, Chrisann Kyi, Taito Esaki, Amy Prawira, Wallace Akerley, Filippo de Braud, Rina Hui, Tian Zhang, Ross A. Soo, Michela Maur, Andrew Weickhardt, Jürgen Krauß, Barbara Deschler-Baier, Allen S. Lau, Tanay S. Samant, Tyler A. Longmire, Niladri Roy Chowdhury, Catherine Sabatos-Peyton, Nidhi Patel, Radha Ramesh, Tiancen Hu, Ana Carion, Daniel Gusenleitner, Padmaja Yerramilli-Rao, Vasileios Askoxylakis, Eunice L. Kwak, David S. Hong - Journal for ImmunoTherapy of Cancer 2022 被引用: 156
- First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors
著者: Timothy A. Yap, David S.P. Tan, Angelika Terbuch, Reece Caldwell, Christina Guo, Boon Cher Goh, Valerie Heong, Noor R. Md. Haris, Saira Bashir, Yvette Drew, David S. Hong, Funda Meric‐Bernstam, Gary Wilkinson, Joseph Hreiki, Antje M. Wengner, Friedhelm Bladt, Andreas Schlicker, Matthias Ludwig, Yinghui Zhou, Li Liu, Sonal Bordia, Ruth Plummer, Eleni Lagkadinou, Johann S. de Bono - Cancer Discovery 2020 被引用: 256
- Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
著者: Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Heinz‐Josef Lenz, Anthony M. Magliocco, Dipen M. Maru, Yibing Yan, Richard B. Lanman, Ganiraju C. Manyam, David S. Hong, Alexey V. Sorokin, Chloé E. Atreya, Luis A. Díaz, Carmen J. Allegra, Kanwal Raghav, Stephen E Wang, Christopher H. Lieu, Shannon McDonough, Philip A. Philip, Howard S. Höchster - Journal of Clinical Oncology 2020 被引用: 391
- Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
著者: Johann S. de Bono, Nicole Concin, David S. Hong, Fiona Thistlethwaite, Jean-Pascal Machiels, Hendrik‐Tobias Arkenau, Ruth Plummer, Robert H. Jones, Dorte Nielsen, Kristian Windfeld, Srinivas Ghatta, Brian M. Slomovitz, James Spicer, Jeffrey Yachnin, Joo Ern Ang, Paul Morten Mau-Sørensen, Martin Förster, Dearbhaile Catherine Collins, Emma Dean, Reshma Rangwala, Ulrik Lassen - The Lancet Oncology 2019 被引用: 230
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
著者: David S. Hong, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Tianyuan Zhou, Joanna Schmidt, Minji Jo, Samantha J. Lee, Mason Yamashita, Steven G. Hughes, Luis Fayad, Sarina A. Piha‐Paul, Murali V.P. Nadella, Morvarid Mohseni, Deborah Lawson, Corinne Reimer, David C. Blakey, Xiaokun Xiao, Jeff Hsu, Alexey S. Revenko, Brett P. Monia, A. Robert MacLeod - Science Translational Medicine 2015 被引用: 440
- Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
著者: Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes, Mauricio S. Caetano, Hari Menon, Nathan Comeaux, Taylor R. Cushman, Jonathan E. Schoenhals, Alexandra P. Cadena, Timothy P. Reilly, Dawei Chen, Fatemeh Masrorpour, Ailin Li, David S. Hong, Adi Diab, Quynh‐Nhu Nguyen, Isabella C. Glitza, Renata Ferrarotto, Stephen G. Chun, María Angélica Cortez, James W. Welsh - Journal for ImmunoTherapy of Cancer 2020 被引用: 212
- Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer
著者: D. Ross Camidge, Fabrice Barlési, Jonathan W. Goldman, Daniel Morgensztern, Rebecca S. Heist, Everett E. Vokes, Alexander I. Spira, Eric Angevin, Wu‐Chou Su, David S. Hong, John H. Strickler, Monica Motwani, Martin Dunbar, Apurvasena Parikh, Elysa Noon, Vincent Blot, Jun Wu, Karen Kelly - Journal of Clinical Oncology 2022 被引用: 104
- Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results
著者: Raffit Hassan, Marcus O. Butler, Roisin E. O’Cearbhaill, David Y. Oh, Melissa L. Johnson, Kevin Zikaras, Munisha Smalley, Michael G. Ross, János L. Tanyi, Azam Ghafoor, Nirali N. Shah, Babak Saboury, Liang Cao, Alfonso Quintás‐Cardama, David S. Hong - Nature Medicine 2023 被引用: 103
- Intratumoral Injection of Clostridium novyi -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
著者: Filip Jankú, Halle Huihong Zhang, Abdulmohammad Pezeshki, Sanjay Goel, Ravi Murthy, Andrea Wang‐Gillam, Dale R. Shepard, Thorunn Helgason, Tyler Masters, David S. Hong, Sarina A. Piha‐Paul, Daniel D. Karp, Mark Klang, Steven Y. Huang, Divya Sakamuri, Anjali Raina, Jean Torrisi, Stephen B. Solomon, Alice S. Weissfeld, Ernest Trevino, Gary DeCrescenzo, Amanda Collins, Maria Miller, Jennifer L. Salstrom, Ronald L. Korn, Linping Zhang, Saurabh Saha, Alexey A. Leontovich, David Tung, Brent L. Kreider, Mary Varterasian, Khashayarsha Khazaie, Mrinal M. Gounder - Clinical Cancer Research 2020 被引用: 155
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
著者: Matthew J. Reilley, Patricia McCoon, Carl Cook, Paul D. Lyne, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Michael A. Curran, Qinying Liu, Tianyuan Zhou, Joanna Schmidt, Minji Jo, Samantha J. Lee, Mason Yamashita, Steven G. Hughes, Luis Fayad, Sarina A. Piha‐Paul, Murali V.P. Nadella, Xiaokun Xiao, Jeff Hsu, Alexey S. Revenko, Brett P. Monia, A. Robert MacLeod, David S. Hong - Journal for ImmunoTherapy of Cancer 2018 被引用: 288
